Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives.


Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 21 02 2018
accepted: 13 11 2018
pubmed: 30 11 2018
medline: 15 5 2019
entrez: 29 11 2018
Statut: ppublish

Résumé

Melanoma can be prevented through reducing sun exposure and detected early by increasing examination of skin for lesions. First-degree relatives of melanoma cases have higher risk than the general population and, therefore, could be targets of behavioral interventions through families. We tested the effects of a family-based web delivered intervention to melanoma families on the melanoma risk reduction behaviors of first-degree relatives of melanoma cases. A total of 313 families that included one first-degree relative were recruited to join this randomized trial. All intervention families received access to the Suntalk website developed to promote family communication and behavioral risk reduction among families of melanoma survivors. First degree relatives in the intervention arm significantly increased their yearly performance of both skin self examination and thorough provider examination from baseline to 12-month follow-up while the control FDRs decreased their yearly performance of both of those behaviors (p's = 0.006 and 0.005, respectively). Several sun protection behaviors increased significantly in FDRs in the intervention arm but not the control arm, including wearing a covering on the head (p = 0.005), staying in available shade (p = 0.008), and avoiding sun exposure during peak hours (p = 0.010). Some of these changes were mediated by perceptions of risk and other process variables. A web-based intervention can reduce risk of melanoma through changes in relevant behaviors among first-degree relatives of melanoma survivors. Future research should identify methods for making this type of intervention accessible to more families and for broadening the reach to other types of cancer families. This program can be provided to melanoma families to improve their sun protection and screening behaviors, at the point of diagnosis.

Identifiants

pubmed: 30483971
doi: 10.1007/s10552-018-1096-y
pii: 10.1007/s10552-018-1096-y
pmc: PMC6436968
mid: NIHMS1514938
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-233

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA107430
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008433
Pays : United States
Organisme : NCI NIH HHS
ID : CA107430
Pays : United States

Références

J Behav Med. 2006 Oct;29(5):419-34
pubmed: 16855870
JAMA Dermatol. 2016 Aug 1;152(8):889-96
pubmed: 27276088
Cancer. 2006 Aug 15;107(4):806-14
pubmed: 16832795
J Clin Oncol. 1994 Apr;12(4):843-50
pubmed: 8151327
Am J Prev Med. 2007 Jun;32(6):517-24
pubmed: 17533068
Eur J Cancer. 2003 Jul;39(11):1517-24
pubmed: 12855257
J Health Commun. 2017 Mar;22(3):198-204
pubmed: 28248624
J Cancer Surviv. 2015 Jun;9(2):279-86
pubmed: 25425205
Arch Dermatol. 2012 May;148(5):621-7
pubmed: 22250188
Community Genet. 2003;6(3):171-7
pubmed: 15237201
Health Psychol. 2010 Nov;29(6):583-93
pubmed: 21090893
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Contemp Clin Trials. 2012 Jan;33(1):85-92
pubmed: 22001361
Arch Dermatol. 2008 Apr;144(4):553-4
pubmed: 18427057
Psychooncology. 2010 Oct;19(10):1102-11
pubmed: 20119933
Fam Community Health. 2006 Jan-Mar;29(1):28-42
pubmed: 16340676
Ann Behav Med. 2007 Nov-Dec;34(3):275-86
pubmed: 18020937
Health Educ Behav. 2010 Aug;37(4):479-89
pubmed: 20157016
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1813-24
pubmed: 24097199
Prev Med. 2004 Oct;39(4):798-803
pubmed: 15351548
Arch Dermatol. 2011 Nov;147(11):1269-75
pubmed: 21768448
J Invest Dermatol. 2013 Mar;133(3):583-585
pubmed: 23399817
Ann Intern Med. 2010 Jun 1;152(11):726-32
pubmed: 20335313

Auteurs

Deborah J Bowen (DJ)

Bioethics and Humanities, University of Washington, Seattle, WA, 98195, USA. dbowen@uw.edu.

Jennifer Hay (J)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Hendrika Meischke (H)

Health Services, University of Washington, Seattle, WA, 98195, USA.

Joni A Mayer (JA)

Graduate School of Public Health, San Diego State University, San Diego, CA, 92182, USA.

Julie Harris-Wai (J)

University of California, San Francisco, San Francisco, CA, USA.

Wylie Burke (W)

Bioethics and Humanities, University of Washington, Seattle, WA, 98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH